TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations

Multisystem proteinopathy (MSP) involves disturbances of stress granule (SG) dynamics and autophagic protein degradation that underlie the pathogenesis of a spectrum of degenerative diseases that affect muscle, brain, and bone. Specifically, identical mutations in the autophagic adaptor SQSTM1 can cause varied penetrance of 4 distinct phenotypes: amyotrophic lateral sclerosis (ALS), frontotemporal dementia, Paget’s disease of the bone, and distal myopathy. It has been hypothesized that clinical pleiotropy relates to additional genetic determinants, but thus far, evidence has been lacking. Here, we provide evidence that a TIA1 (p.N357S) variant dictates a myodegenerative phenotype when inherited, along with a pathogenic SQSTM1 mutation. Experimentally, the TIA1-N357S variant significantly enhances liquid-liquid–phase separation in vitro and impairs SG dynamics in living cells. Depletion of SQSTM1 or the introduction of a mutant version of SQSTM1 similarly impairs SG dynamics. TIA1-N357S–persistent SGs have increased association with SQSTM1, accumulation of ubiquitin conjugates, and additional aggregated proteins. Synergistic expression of the TIA1-N357S variant and a SQSTM1-A390X mutation in myoblasts leads to impaired SG clearance and myotoxicity relative to control myoblasts. These findings demonstrate a pathogenic connection between SG homeostasis and ubiquitin-mediated autophagic degradation that drives the penetrance of an MSP phenotype.

[1]  Charles D. Smith,et al.  Genotype‐phenotype study in patients with valosin‐containing protein mutations associated with multisystem proteinopathy , 2018, Clinical genetics.

[2]  M. Mesulam,et al.  TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics , 2017, Neuron.

[3]  A. Hyman,et al.  An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function , 2017, The EMBO journal.

[4]  T. Chou,et al.  Keap1/Cullin3 Modulates p62/SQSTM1 Activity via UBA Domain Ubiquitination. , 2017, Cell reports.

[5]  A. Singleton,et al.  Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis , 2016, Neurobiology of Aging.

[6]  G. Leo,et al.  A Surveillance Function of the HSPB8-BAG3-HSP70 Chaperone Complex Ensures Stress Granule Integrity and Dynamism. , 2016, Molecular cell.

[7]  E. Buratti,et al.  Physiological functions and pathobiology of TDP‐43 and FUS/TLS proteins , 2016, Journal of neurochemistry.

[8]  B. Udd,et al.  Targeted next-generation sequencing assay for detection of mutations in primary myopathies , 2016, Neuromuscular Disorders.

[9]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[10]  A. Kanagaraj,et al.  Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization , 2015, Cell.

[11]  A. Pestronk,et al.  SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles , 2015, Neurology.

[12]  J. Taylor,et al.  Multisystem proteinopathy , 2015, Neurology.

[13]  G. Frisoni,et al.  Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study , 2015, Neurobiology of Aging.

[14]  A. Pestronk,et al.  Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis , 2015, Neuromuscular Disorders.

[15]  L. Kunkel,et al.  A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G). , 2014, Human molecular genetics.

[16]  D. Rubinsztein,et al.  Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly , 2014, Cell Death and Differentiation.

[17]  M. Searle,et al.  SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD. , 2014, Experimental cell research.

[18]  Lorne Zinman,et al.  Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.

[19]  D. Rubinsztein,et al.  Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species , 2014, Journal of Cell Science.

[20]  J. Hardy,et al.  SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. , 2013, JAMA neurology.

[21]  A. Hiniker,et al.  Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies , 2013, Acta neuropathologica communications.

[22]  R. Parker,et al.  Eukaryotic Stress Granules Are Cleared by Autophagy and Cdc48/VCP Function , 2013, Cell.

[23]  Bjarne Udd,et al.  Welander distal myopathy is caused by a mutation in the RNA‐binding protein TIA1 , 2013, Annals of neurology.

[24]  Michael Benatar,et al.  Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.

[25]  C. Baker-Austin,et al.  Isolation of Pandemic Vibrio parahaemolyticus from UK Water and Shellfish Produce , 2013, Microbial Ecology.

[26]  V. Meininger,et al.  Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology , 2013, Acta Neuropathologica.

[27]  Daniel G. Miller,et al.  Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2 , 2012, Nature Genetics.

[28]  Sonja W. Scholz,et al.  Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[29]  M. Sherman,et al.  Association of translation factor eEF1A with defective ribosomal products generates a signal for aggresome formation , 2012, Journal of Cell Science.

[30]  S. Ajroud‐Driss,et al.  SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.

[31]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[32]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[33]  J. Ju,et al.  Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. , 2010, Human molecular genetics.

[34]  A. Langston,et al.  Randomized trial of intensive bisphosphonate treatment versus symptomatic management in paget's disease of bone , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  D. Piwnica-Worms,et al.  Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease , 2009, The Journal of cell biology.

[36]  V. Askanas,et al.  p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis , 2009, Acta Neuropathologica.

[37]  J. Haines,et al.  Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2009, Science.

[38]  A. Pestronk,et al.  TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[39]  J. Morris,et al.  TDP‐43 A315T mutation in familial motor neuron disease , 2008, Annals of neurology.

[40]  G. Bjørkøy,et al.  p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy* , 2007, Journal of Biological Chemistry.

[41]  Jacques P. Brown,et al.  Sequestosome 1: Mutation Frequencies, Haplotypes, and Phenotypes in Familial Paget's Disease of Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  S. Mehta,et al.  Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. , 2006, Bone.

[43]  M. Brandi,et al.  Two Novel Mutations at Exon 8 of the Sequestosome 1 (SQSTM1) Gene in an Italian Series of Patients Affected by Paget's Disease of Bone (PDB) , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  W. Hul,et al.  Evaluation of the Role of the SQSTM1 Gene in Sporadic Belgian Patients with Paget’s Disease , 2004, Calcified Tissue International.

[45]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[46]  L. Hocking,et al.  Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. , 2002, Human molecular genetics.

[47]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[48]  Wei Li,et al.  RNA-Binding Proteins Tia-1 and Tiar Link the Phosphorylation of Eif-2α to the Assembly of Mammalian Stress Granules , 1999, The Journal of cell biology.

[49]  A. Singleton,et al.  Rare variants in SQSTM 1 and VCP genes and risk of sporadic inclusion body myositis , 2016 .

[50]  A. Verma.  Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis , 2010 .

[51]  Charles D. Smith,et al.  APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) , 2007, Genetics in Medicine.

[52]  L. Welander.  Homozygous appearance of distal myopathy. , 1957, Acta genetica et statistica medica.